India News | Written by J Sam Daniel Stalin, Edited by Akhil Kumar | Saturday February 4, 2023
Global Pharma Healthcare, the drug manufacturer at the centre of the controversy, has said it's working closely with the US Food and Drug Administration (FDA).
www.ndtv.com